黑料网

Impact of Genomic Medicine on the Future of Neuropsychopharmacology

Ramón Cacabelos

Editorial: J Neuropsychopharmacol Mental Health 2016, 1:e101

Epigenetic Mechanisms on Food Addiction

Enrico Patrono

Editorial: J Neuropsychopharmacol Mental Health 2016, 1:e102

Neurobiological Evidence in Alcohol Addiction Can Help Pharmacological Treatment Personalization

Teo Vignoli, Elisa Martino and Fabio Caputo

Editorial: J Neuropsychopharmacol Mental Health

DOI: 10.4172/2472-095X.1000e103

Prevalence and Correlates of Co-occurring Substance Use Disorder among Patients with Severe Mental Disorder at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia

Bereket Duko, Getinet Ayano, Lulu Bekana and Dawit Assefa

Research Article: J Neuropsychopharmacol Mental Health

DOI: 10.4172/2472-095X.1000101

Psychiatric and Mental Health Core Capabilities and Learning Outcomes Developed in Nurse Practitioner Programmes in Australia and the United States of America

Andrew Cashin, Roger Green and Thomas Buckley

Review Article: J Neuropsychopharmacol Mental Health

DOI: 10.4172/2472-095X.1000102

Gene Expression Analysis of Fibroblasts from Patients with Bipolar Disorder

Logotheti Marianthi, Papadodima Olga, Chatziioannou Aristotelis, Venizelos Nikolaos and Kolisis Fragiskos

Research Article: J Neuropsychopharmacol Mental Health

DOI: 10.4172/2472-095X.1000103

Level of Insulin Resistance in Schizophrenia Patients and Its Association with Treatment with Antipsychotics

Prasenjit Ray and CRJ Khess

Research Article: J Neuropsychopharmacol Mental Health

DOI: 10.4172/2472-095X.1000104

Hyponatremia and Chewing Gum in a Patient with Anorexia Nervosa

Andres Gomez Del Barrio, Ines Madrazo Rio-Hortega and Maria del Castanar Garcia Gomez

Case Report: J Neuropsychopharmacol Mental Health 2016

DOI: 10.4172/2472-095X.1000105